Acknowledgements
We would like to thank Mariann Lassenius and Iiro Toppila, Medaffcon for their significant contribution in the study design. We would also like to thank Josefine Persson, AstraZeneca for her valuable input to the study design and reviewing of the manuscript.
Authorship: STS, KN, GT, LL contributed to study design. All authors STS, JA, BM, JH, KN, GT and LL contributed to interpretation of data and were involved in manuscript writing and revision. JA and JH contributed to data acquisition and analyses. All authors STS, JA, BM, JH, KN, GT and LL gave final approval for manuscript publication and agreed to be accountable for all aspects of their work.
The study was funded by AstraZeneca Nordic, Sweden.